Peginterferon alfa-2a (Pooyesh Darou Pharmaceuticals)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePeginterferon alfa-2a (Pooyesh Darou Pharmaceuticals)
Drug Alias Namepeginterferon alfa-2a
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsHepatitis CHepatitis B
Global Approved IndicationsHepatitis CHepatitis B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIran
Original Approved Date2008/01/01
Country/TerritoryIran
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesPooyesh Darou
China Registration ClassN/A

Develop Information

Active CompaniesPooyesh Darou
Inactive CompaniesKermanshah University Of Medical SciencesTehran University Of Medical Sciences
Active IndicationsHepatitis CHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeL03AB11
Related LinksN/A